PPT-Brain Oxygen Optimization in Severe TBI-Phase 3 (BOOST-3)

Ramon DiazArrastia MD PhD Scientific PI Lori Shutter MD Clinical PI William Barsan MD Contact PI CCC SIREN Sharon Yeatts PhD Statistical PI DCC SIREN Brain Tissue Oxygen Monitors FDAapproval. Anne Felicia Ambrose, MD, MS. Medical Director, Traumatic Brain Injury Program. Mount Sinai School of Medicine. New York , NY. NY-TBI Model Systems. Case. 63 year old man. Accountant. Mild cognitive impairments 3 years ago following a cardiac stent. Assistant Professor, Department of Neurosurgery, . Neurocritical. Care. Assistant Professor, Department of Emergency Medicine. Understanding Traumatic Brain Injury. Outline. Statistics. Defining TBI. James F. . Malec. , PhD, ABPP-. Cn. , . Rp. Professor & Research Director. PM&R, Indiana University School of Medicine. & Rehabilitation Hospital of Indiana. Emeritus Professor of Psychology, Mayo Clinic. What Have We Learned?. . A Functional and Molecular Neuroimaging Perspective. Emily Stern, . MD. Director, Functional Neuroimaging Laboratory. Director, Functional and Molecular Neuroimaging. Departments of Radiology and Psychiatry. intellectual disability& Multiple Disabilities . Teaching Students With Disabilities . Ryan Williams . Marjaan. . Sirdar. Saed. . Adbi. Traumatic Brain Injury. Often referred to as TBI. Traumatic brain injury (TBI) is a serious public health problem in the United States. Each year, traumatic brain injuries contribute to a substantial number of deaths and cases of permanent disability. In 2010 2.5 million TBIs occurred either as an isolated injury or along with other injuries.. Hal S. Wortzel, MD. Director, MIRECC Neuropsychiatric Consultation Services and Psychiatric Fellowship. VISN 19 MIRECC, Denver Veterans Hospital. Assistant Professor of Psychiatry. Faculty - Neurobehavior Disorders Program and Division of Forensic Psychiatry. Matthew Sharrock, MD. PGY4 Neurology. Overview. Introduction. Diagnosis and Classification. Primary and Secondary Injury. Early . TBI . management. Experimental Data & Clinical . Trials. Future Directions. Lead Consultant, Cognitive/Neurological Team. . Stephen . Heck, . M.Res. . M.A.. PhD Student, Social & Behavioral . Sciences, . West Virginia . University.  . . 1. Session Description. PIs. : . Ramon Diaz-Arrastia, M.D., Ph.D. . and . Frederick Korley, M.D., Ph.D.. The Need. Limited objective tools for monitoring secondary brain injury. Scientific Rationale. Preliminary evidence. Korley et al. J . Clayton Anderson, MD. Seattle Children’s Hospital. . Updated 07/2020. Disclosures. No relevant financial relationships to disclose. Objectives. Review global epidemiology. Define traumatic brain injury (TBI) pathophysiology and principal clinical objectives. TBI--Phase . 3. Protocol Introduction and Scientific Rationale. Ramon Diaz-Arrastia, MD, PhD. Professor of Neurology, University of Pennsylvania. BOOST-3 Study Chair. Does . BOOSTing. Cerebral Oxygenation Boost TBI Outcomes?. InFuSE. ) Development and Initial Outcomes. Shane Chanpimol, PT, DPT. Polytrauma. /TBI Research Fellow. Physical Medicine & Rehabilitation. Washington DC VA Medical Center. Lucile Lisle, CTRS. Certified Recreation Therapist. William C. Walker, MD. Ernst & Helga Prosser Professor. VCU . Dept. PM&R. 10/25/23. Besides injury factors and patient characteristics, PROGNOSIS depends on:. Population considered. All cases. B. rain . I. njury . T. reatment Trial: A Multicenter Phase II Adaptive Clinical Trial. . Gaylan. . Rockswold. , MD, PhD, Principal Investigator. Thomas Bergman, MD, Site Principal Investigator. Overview.